50 participants
Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2012-06-25
- Start Date:
- 2012-02-29
- Completion:
- 2017-02-28
Conditions
- Chronic Myeloid Leukemia
Interventions
- DRUG
No Results Yet